These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25077114)

  • 21. The Australasian Resuscitation In Sepsis Evaluation: Fluids or vasopressors in emergency department sepsis (ARISE FLUIDS), a multi-centre observational study describing current practice in Australia and New Zealand.
    Keijzers G; Macdonald SP; Udy AA; Arendts G; Bailey M; Bellomo R; Blecher GE; Burcham J; Coggins AR; Delaney A; Fatovich DM; Fraser JF; Harley A; Jones P; Kinnear FB; May K; Peake S; Taylor DM; Williams P;
    Emerg Med Australas; 2020 Aug; 32(4):586-598. PubMed ID: 32043315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy septic and vasodilatory shock.
    Lamontagne F; Day AG; Meade MO; Cook DJ; Guyatt GH; Hylands M; Radermacher P; Chrétien JM; Beaudoin N; Hébert P; D'Aragon F; Meziani F; Asfar P
    Intensive Care Med; 2018 Jan; 44(1):12-21. PubMed ID: 29260272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock.
    Colon Hidalgo D; Patel J; Masic D; Park D; Rech MA
    J Crit Care; 2020 Feb; 55():145-148. PubMed ID: 31731173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
    Musallam N; Altshuler D; Merchan C; Zakhary B; Aberle C; Papadopoulos J
    Ann Pharmacother; 2018 Aug; 52(8):733-739. PubMed ID: 29560736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coefficient of Variation of Coarsely Sampled Heart Rate is Associated With Early Vasopressor Independence in Severe Sepsis and Septic Shock.
    Brown SM; Tate MQ; Jones JP; Kuttler KG; Lanspa MJ; Rondina MT; Grissom CK; Mathews VJ
    J Intensive Care Med; 2015 Oct; 30(7):420-5. PubMed ID: 24578465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of parameters associated with hypotension requiring vasopressor support after carotid angioplasty and stenting.
    Trocciola SM; Chaer RA; Lin SC; Ryer EJ; De Rubertis B; Morrissey NJ; McKinsey J; Kent KC; Faries PL
    J Vasc Surg; 2006 Apr; 43(4):714-20. PubMed ID: 16616226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypotension Risk Based on Vasoactive Agent Discontinuation Order in Patients in the Recovery Phase of Septic Shock.
    Sacha GL; Lam SW; Duggal A; Torbic H; Reddy AJ; Bauer SR
    Pharmacotherapy; 2018 Mar; 38(3):319-326. PubMed ID: 29328496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous use of traditional Chinese medicine (si-ni-tang) to treat septic shock patients: study protocol for a randomized controlled trial.
    Chen HC; Chen WC; Lin KH; Chen YH; Lo LC; Lee TC; Hsia TC; Wang CH; Wu SH; Hsu HW; Chang YJ; Huang YC; Ku TH; Horng MH
    Trials; 2011 Aug; 12():199. PubMed ID: 21864392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 12-year study evaluating the outcomes and predictors of mortality in critically ill cancer patients admitted with septic shock.
    Awad WB; Nazer L; Elfarr S; Abdullah M; Hawari F
    BMC Cancer; 2021 Jun; 21(1):709. PubMed ID: 34130642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Predictive value of glycemic variability within 6 hours on the short-term prognosis of patients with septic shock].
    Sun C; Zhong B; Shen H; Zhu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jan; 33(1):28-32. PubMed ID: 33565396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).
    Shankar-Hari M; Phillips GS; Levy ML; Seymour CW; Liu VX; Deutschman CS; Angus DC; Rubenfeld GD; Singer M;
    JAMA; 2016 Feb; 315(8):775-87. PubMed ID: 26903336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of Vasopressin Use for Adults with Septic Shock.
    Vail EA; Gershengorn HB; Hua M; Walkey AJ; Wunsch H
    Ann Am Thorac Soc; 2016 Oct; 13(10):1760-1767. PubMed ID: 27404213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mortality rates increase dramatically below a systolic blood pressure of 105-mm Hg in septic surgical patients.
    Clarke DL; Chipps JA; Sartorius B; Bruce J; Laing GL; Brysiewicz P
    Am J Surg; 2016 Nov; 212(5):941-945. PubMed ID: 27290634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension: A Randomized Clinical Trial.
    Lamontagne F; Richards-Belle A; Thomas K; Harrison DA; Sadique MZ; Grieve RD; Camsooksai J; Darnell R; Gordon AC; Henry D; Hudson N; Mason AJ; Saull M; Whitman C; Young JD; Rowan KM; Mouncey PR;
    JAMA; 2020 Mar; 323(10):938-949. PubMed ID: 32049269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of dexmedetomidine on vasopressor requirements in patients with septic shock: a subgroup analysis of the Sedation Practice in Intensive Care Evaluation [SPICE III] Trial.
    Cioccari L; Luethi N; Bailey M; Shehabi Y; Howe B; Messmer AS; Proimos HK; Peck L; Young H; Eastwood GM; Merz TM; Takala J; Jakob SM; Bellomo R;
    Crit Care; 2020 Jul; 24(1):441. PubMed ID: 32678054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Septic shock with no diagnosis at 24 hours: a pragmatic multicenter prospective cohort study.
    Contou D; Roux D; Jochmans S; Coudroy R; Guérot E; Grimaldi D; Ricome S; Maury E; Plantefève G; Mayaux J; Mekontso Dessap A; Brun-Buisson C; de Prost N
    Crit Care; 2016 Nov; 20(1):360. PubMed ID: 27816060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Hydrocortisone Continuous Infusion Versus Intermittent Boluses in Resolution of Septic Shock.
    Hoang H; Wang S; Islam S; Hanna A; Axelrad A; Brathwaite C
    P T; 2017 Apr; 42(4):252-255. PubMed ID: 28381918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Vasopressor Duration in Septic Shock Patients With and Without Cirrhosis.
    Durst MM; Eitzen EA; Benken ST
    Ann Pharmacother; 2021 Aug; 55(8):970-979. PubMed ID: 33327736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liberal vs. conservative vasopressor use to maintain mean arterial blood pressure during resuscitation of septic shock: an observational study.
    Subramanian S; Yilmaz M; Rehman A; Hubmayr RD; Afessa B; Gajic O
    Intensive Care Med; 2008 Jan; 34(1):157-62. PubMed ID: 17924093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does body weight impact the efficacy of vasopressin therapy in the management of septic shock?
    Miller JT; Welage LS; Kraft MD; Alaniz C
    J Crit Care; 2012 Jun; 27(3):289-93. PubMed ID: 21855282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.